Showing 461 - 480 results of 3,189 for search '"vaccination"', query time: 0.08s Refine Results
  1. 461

    Humoral Immune Response to Keyhole Limpet Haemocyanin, the Protein Carrier in Cancer Vaccines by A. Kantele, M. P. Häkkinen, J. Zivny, C. O. Elson, J. Mestecky, J. M. Kantele

    Published 2011-01-01
    “…KLH serving as protein carrier in several vaccines, the homing profile of KLH-specific response may be applicable to the cancer antigen parts in the same vaccines. …”
    Get full text
    Article
  2. 462

    Dynamical Analysis of SIR Epidemic Model with Nonlinear Pulse Vaccination and Lifelong Immunity by Wencai Zhao, Juan Li, Xinzhu Meng

    Published 2015-01-01
    “…SIR epidemic model with nonlinear pulse vaccination and lifelong immunity is proposed. Due to the limited medical resources, vaccine immunization rate is considered as a nonlinear saturation function. …”
    Get full text
    Article
  3. 463
  4. 464
  5. 465
  6. 466

    Influence of Infection Delay on the Covid-19 Pandemic with Vaccination Control: Modeling and Simulation by Rami Raad Saadi, Hassan F. Al-Husseiny

    Published 2025-01-01
    “… In this work, we formulate a mathematical model of the killer COVID-19 pandemic with time delay and some governmental measures that include vaccine subsidies to understand the dynamic behavior of COVID-19. …”
    Get full text
    Article
  7. 467
  8. 468

    Vaccinated, Recovered and Tested in the Workplace: Situation in Firms in Lower Saxony at the End of 2021 by Stephan L. Thomsen, Johannes Trunzer

    Published 2022-02-01
    “…Abstract The amendment of the Infection Protection Act at the end of November 2021 made it possible to map vaccinated, recovered and tested employees at the firm-level for the first time after the start of vaccinations in Germany. …”
    Get full text
    Article
  9. 469

    Estimation of invasive pneumococcal disease dynamics parameters and the impact of conjugate vaccination in Australia by Karyn L. Sutton, H.T. Banks, Carlos Castillo-Chávez

    Published 2007-12-01
    “…Recent advances in the development of vaccines for theseinfections have raised questions concerning their widespread and/or long-termuse. …”
    Get full text
    Article
  10. 470
  11. 471
  12. 472
  13. 473
  14. 474
  15. 475

    Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States by Abhijeet Waghray, Nisheet Waghray, Hicham Khallafi, K. V. Narayanan Menon

    Published 2016-01-01
    “…Prior studies assessing vaccination rates in patients with cirrhosis have specific limitations and to date no study has provided a comprehensive evaluation of vaccination rates in patients with cirrhosis in the United States. …”
    Get full text
    Article
  16. 476
  17. 477
  18. 478

    WT1 Peptide Cancer Vaccine for Patients with Hematopoietic Malignancies and Solid Cancers by Yoshihiro Oka, Akihiro Tsuboi, Olga A. Elisseeva, Hiroko Nakajima, Fumihiro Fujiki, Manabu Kawakami, Toshiaki Shirakata, Sumiyuki Nishida, Naoki Hosen, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama

    Published 2007-01-01
    “…These results strongly suggested that the WT1 peptide cancer vaccine had efficacy in the clinical setting because clinical responses, including reduction of leukemic blast cells or regression of tumor masses, were observed after the WT1 vaccination in patients with hematopoietic malignancies or solid cancers. …”
    Get full text
    Article
  19. 479
  20. 480